2Wallentin L,Lagerqvist B, Husted S. For the FRISC ⅡInvestigators: outcome at 1 year after an invasive compared to a non-invasive strategy in unstable coronary artery disease: the FRISC Ⅱ invasive randomised trial. Lancet,2000,356:9-16. 被引量：1
3Cannon CP,Weintraub WS,Demopoulos LA,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban. N Engl J Med,2001,344:1879-1887. 被引量：1
4Fox KAA, Poole-Wilson PA, Henderson RA,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA-3 randomized trial. Lancet,2002,360:743-751. 被引量：1
5Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment(cooling-off strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA,2003,290:1593-1599. 被引量：1
6Braunwald E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. Circulation,2003,108(Suppl): Ⅲ28-Ⅲ37. 被引量：1
7Cannon CP, McCabe CH, Stone PH,et al.For the TIMI Ⅲ Registry ECG Ancillary Study Investigators. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI Ⅲ Registry ECG Ancillary Study. J Am Coll Cardiol,1997,30:133-140. 被引量：1
8Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of framinlgham risk scores. Circulation,2004,109:1955-1959. 被引量：1
9Sabatine MS, McCabe CH, Morrow DA,et al. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J, 2002,143:966-970. 被引量：1
